Search Results

There are 8238 results for: content related to: Phase I clinical trial of oral rosiglitazone in combination with intravenous carboplatin in cancer-bearing dogs

  1. Rosiglitazone for type 2 diabetes mellitus

    Intervention Review

    The Cochrane Library

    Bernd Richter, Elizabeth Bandeira-Echtler, Karla Bergerhoff, Christine Clar and Susanne H Ebrahim

    Published Online : 18 JUL 2007, DOI: 10.1002/14651858.CD006063.pub2

  2. Regulation of adipose triglyceride lipase by rosiglitazone

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 2, February 2009, Pages: 131–142, L.-F. Liu, A. Purushotham, A. A. Wendel, K. Koba, J. DeIuliis, K Lee and M. A. Belury

    Version of Record online : 17 JUL 2008, DOI: 10.1111/j.1463-1326.2008.00916.x

  3. You have free access to this content
    Rosiglitazone inhibits Kv4.3 potassium channels by open-channel block and acceleration of closed-state inactivation

    British Journal of Pharmacology

    Volume 163, Issue 3, June 2011, Pages: 510–520, I Jeong, BH Choi and SJ Hahn

    Version of Record online : 11 MAY 2011, DOI: 10.1111/j.1476-5381.2011.01210.x

  4. You have free access to this content
    Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone

    Journal of Neurochemistry

    Volume 97, Issue 2, April 2006, Pages: 435–448, Yumin Luo, Wei Yin, Armando P. Signore, Feng Zhang, Zhen Hong, Suping Wang, Steven H. Graham and Jun Chen

    Version of Record online : 15 MAR 2006, DOI: 10.1111/j.1471-4159.2006.03758.x

  5. You have free access to this content
    Rosiglitazone selectively inhibits KATP channels by acting on the KIR6 subunit

    British Journal of Pharmacology

    Volume 167, Issue 1, September 2012, Pages: 26–36, Lei Yu, Xin Jin, Ningren Cui, Yang Wu, Zhenda Shi, Daling Zhu and Chun Jiang

    Version of Record online : 3 AUG 2012, DOI: 10.1111/j.1476-5381.2012.01934.x

  6. Cardiovascular risk and thiazolidinediones—what do meta-analyses really tell us?

    Diabetes, Obesity and Metabolism

    Volume 12, Issue 12, December 2010, Pages: 1023–1035, G. Schernthaner and R. J. Chilton

    Version of Record online : 12 JUL 2010, DOI: 10.1111/j.1463-1326.2010.01262.x

  7. A Review of Rosiglitazone in Type 2 Diabetes Mellitus

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 21, Issue 9, September 2001, Pages: 1082–1099, Amy L. Werner and Maryann T. Travaglini

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.21.13.1082.34615

  8. You have free access to this content
    Effects of rosiglitazone on the configuration of action potentials and ion currents in canine ventricular cells

    British Journal of Pharmacology

    Volume 163, Issue 3, June 2011, Pages: 499–509, N Szentandrássy, G Harmati, L Bárándi, J Simkó, B Horváth, J Magyar, T Bányász, I Lőrincz, A Szebeni, V Kecskeméti and PP Nánási

    Version of Record online : 11 MAY 2011, DOI: 10.1111/j.1476-5381.2011.01215.x

  9. Long-term 2-year safety and efficacy of vildagliptin compared with rosiglitazone in drug-naïve patients with type 2 diabetes mellitus

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 6, June 2009, Pages: 571–578, J. Rosenstock, M. Niggli and M. Maldonado-Lutomirsky

    Version of Record online : 5 APR 2009, DOI: 10.1111/j.1463-1326.2008.01021.x

  10. You have free access to this content
    Mechanisms responsible for beneficial and adverse effects of rosiglitazone in a rat model of acute cardiac ischaemia–reperfusion

    Experimental Physiology

    Volume 98, Issue 5, May 2013, Pages: 1028–1037, Siripong Palee, Punate Weerateerangkul, Kroekkiat Chinda, Siriporn C. Chattipakorn and Nipon Chattipakorn

    Version of Record online : 11 FEB 2013, DOI: 10.1113/expphysiol.2012.070433

  11. You have free access to this content
    Effect of rosiglitazone on cardiac electrophysiology, infarct size and mitochondrial function in ischaemia and reperfusion of swine and rat heart

    Experimental Physiology

    Volume 96, Issue 8, August 2011, Pages: 778–789, Siripong Palee, Punate Weerateerangkul, Sirirat Surinkeaw, Siriporn Chattipakorn and Nipon Chattipakorn

    Version of Record online : 7 JUL 2011, DOI: 10.1113/expphysiol.2011.057885

  12. You have full text access to this OnlineOpen article
    Effect and cardiovascular safety of adding rosiglitazone to insulin therapy in type 2 diabetes: A meta-analysis

    Journal of Diabetes Investigation

    Volume 6, Issue 1, January 2015, Pages: 78–86, Yu Lu, Delin Ma, Weijie Xu, Shiying Shao and Xuefeng Yu

    Version of Record online : 18 JUN 2014, DOI: 10.1111/jdi.12246

  13. Multiple-Dose Administration of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Does Not Alter the Single-Dose Pharmacokinetics of Rosiglitazone in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 47, Issue 2, February 2007, Pages: 159–164, Mr Goutam C. Mistry, Dr Arthur J. Bergman, Dr Wen-Lin Luo, Mr Caroline Cilissen, Dr Wouter Haazen, Dr Michael J. Davies, Dr Keith M. Gottesdiener, Dr John A. Wagner and Dr Gary A. Herman

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270006297007

  14. You have free access to this content
    The effects of febuxostat on the pharmacokinetic parameters of rosiglitazone, a CYP2C8 substrate

    British Journal of Clinical Pharmacology

    Volume 74, Issue 2, August 2012, Pages: 327–335, Himanshu Naik, Jing-tao Wu, Robert Palmer and Lachy McLean

    Version of Record online : 10 JUL 2012, DOI: 10.1111/j.1365-2125.2012.04182.x

  15. Individual and Combined Effects of Peroxisome Proliferator-Activated Receptor α and γ Agonists, Fenofibrate and Rosiglitazone, on Biomarkers of Lipid and Glucose Metabolism in Healthy Nondiabetic Volunteers

    The Journal of Clinical Pharmacology

    Volume 45, Issue 5, May 2005, Pages: 504–513, Dr J. A. Wagner, P. J. Larson, S. Weiss, J. L. Miller, Dr T. W. Doebber, M. S. Wu, Dr D. E. Moller and Dr K. M. Gottesdiener

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270004273136

  16. You have full text access to this OnlineOpen article
    Rosiglitazone treatment and cardiovascular disease in the Veterans Affairs Diabetes Trial

    Diabetes, Obesity and Metabolism

    Volume 17, Issue 10, October 2015, Pages: 949–955, H. Florez, P. D. Reaven, G. Bahn, T. Moritz, S. Warren, J. Marks, D. Reda, W. Duckworth, C. Abraira, R. Hayward, N. Emanuele and from the VADT Research Group

    Version of Record online : 17 JUN 2015, DOI: 10.1111/dom.12487

  17. Database Evaluation of the Effects of Long-Term Rosiglitazone Treatment on Cardiovascular Outcomes in Patients With Type 2 Diabetes

    The Journal of Clinical Pharmacology

    Volume 51, Issue 2, February 2011, Pages: 173–180, Dr Ronen Loebstein, Dr Marina Dushinat, Ms Janet Vesterman-Landes, Dr Barbara Silverman, Dr Nurit Friedman, Dr Itzhak Katzir, Dr Daniel Kurnik, Dr Yossef Lomnicky, Dr Ehud Kokia and Dr Hillel Halkin

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010368281

  18. Primary chemoprevention of endometrial hyperplasia with the peroxisome proliferator-activated receptor gamma agonist rosiglitazone in the PTEN heterozygote murine model

    International Journal of Gynecological Cancer

    Volume 18, Issue 2, March/April 2008, Pages: 329–338, W. WU, J. CELESTINO, M.R. MILAM, K.M. SCHMELER, R.R. BROADDUS, L.H. ELLENSON and K.H. LU

    Version of Record online : 20 JUL 2007, DOI: 10.1111/j.1525-1438.2007.01002.x

  19. You have free access to this content
    Rosiglitazone-activated PPARγ induces neurotrophic factor-α1 transcription contributing to neuroprotection

    Journal of Neurochemistry

    Volume 134, Issue 3, August 2015, Pages: 463–470, Erwan Thouennon, Yong Cheng, Vida Falahatian, Niamh X. Cawley and Yoke Peng Loh

    Version of Record online : 1 JUN 2015, DOI: 10.1111/jnc.13152

  20. Preserved Response to Diuretics in Rosiglitazone-Treated Subjects With Insulin Resistance: A Randomized Double-Blind Placebo-Controlled Crossover Study

    Clinical Pharmacology & Therapeutics

    Volume 89, Issue 4, April 2011, Pages: 587–594, AJ Rennings, FG Russel, Y Li, PM Deen, R Masereeuw, CJ Tack and P Smits

    Version of Record online : 2 MAR 2011, DOI: 10.1038/clpt.2010.360